These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period. Li W, Yi L, Su J, Lu J, Ke C, Zeng H, Guan D, Ma C, Zhang W, Xiao H, Li H, Lin J, Zhang Y. PLoS One; 2013; 8(12):e80515. PubMed ID: 24324604 [Abstract] [Full Text] [Related]
5. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008-2011. Ni H, Yi B, Yin J, Fang T, He T, Du Y, Wang J, Zhang H, Xie L, Ding Y, Gu W, Zhang S, Han Y, Dong H, Su T, Xu G, Cao G. J Clin Virol; 2012 Aug; 54(4):342-8. PubMed ID: 22652041 [Abstract] [Full Text] [Related]
6. Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and children. Zhang Y, Wang L, Liao Y, Liu L, Ma K, Yang E, Wang J, Che Y, Jiang L, Pu J, Guo L, Feng M, Liang Y, Cui W, Yang H, Li Q. Vaccine; 2015 Nov 17; 33(46):6290-7. PubMed ID: 26419198 [Abstract] [Full Text] [Related]
7. Two models for changes of EV71 immunity in infants and young children. Tu X, Wang Y, Zhu F, Chen F. Hum Vaccin Immunother; 2015 Nov 17; 11(6):1429-33. PubMed ID: 25906390 [Abstract] [Full Text] [Related]
8. Dynamic change of mother-source neutralizing antibodies against enterovirus 71 and coxsackievirus A16 in infants. Mao QY, Liao XY, Yu X, Li N, Zhu FC, Zeng Y, Liang ZL, Li FX, Wang JZ, Lu FM, Zhuang H. Chin Med J (Engl); 2010 Jul 17; 123(13):1679-84. PubMed ID: 20819628 [Abstract] [Full Text] [Related]
10. Seroepidemiology of human enterovirus71 and coxsackievirusA16 among children in Guangdong province, China. Li W, Yi L, Su J, Lu J, Zeng H, Guan D, Ma C, Zhang W, Xiao H, Li H, Zhang Y, Lin J, Ke C. BMC Infect Dis; 2013 Jul 15; 13():322. PubMed ID: 23855481 [Abstract] [Full Text] [Related]
14. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, Chu K, Song XF, Yao X, Li JX, Ji H, Zhang YJ, Li L, Pan HX, Xu K, Dai WM, Zhang WW, Deng F, Wang H, Wang JZ. PLoS One; 2012 Jul 15; 7(5):e37206. PubMed ID: 22662137 [Abstract] [Full Text] [Related]
15. Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay. Zhang H, An D, Liu W, Mao Q, Jin J, Xu L, Sun S, Jiang L, Li X, Shao J, Ma H, Huang X, Guo S, Chen H, Cheng T, Yang L, Su W, Kong W, Liang Z, Jiang C. PLoS One; 2014 Jul 15; 9(6):e100545. PubMed ID: 24964084 [Abstract] [Full Text] [Related]
18. The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals. Mao Q, Wang Y, Shao J, Ying Z, Gao F, Yao X, Li C, Ye Q, Xu M, Li R, Zhu F, Liang Z. Hum Vaccin Immunother; 2015 Jul 15; 11(11):2723-33. PubMed ID: 25715318 [Abstract] [Full Text] [Related]